Humana Inc. is a major U.S. health care plan provider with a market cap of $28 billion, offering a variety of insurance products including Medicare, Medicaid, pharmacy benefits, and senior-focused care.

Analysts predict Humana will report an adjusted EPS of $6.32 for Q2 2025, down 9.2% from the previous year. For fiscal 2025, the company is expected to show an adjusted EPS of $16.38, up 1.1% from fiscal 2024.

Despite a 38.8% decrease in shares over the past year, Humana’s Q1 2025 revenue was weaker than expected at $32.1 billion. However, a strong adjusted EPS of $11.58 led to a 1.1% share increase, with positive investor sentiment on improved benefit ratios and operating income.

Analysts have a “Moderate Buy” rating on Humana stock, with some recommending “Strong Buy” and others “Hold.” The stock is currently trading below the average analyst price target of $289.05.

Read more at Yahoo Finance: Here’s What to Expect From Humana’s Next Earnings Report